PK Biosciences is spin off from the translational research of the Iowa State University, Ames, IA. We are developing innovative medicines that are targeted against selective PKC isoforms. These are involved in the apoptotic cell death pathway, observed in many neurodegenerative disorders.

PK Biosciences Corporation is a private held company.